SCIENTIFIC PANEL

Tallal
Younis
NOYCIA Chair
MBBCh, FRCP (UK)
Jamil
Asselah
MD
Medical
Oncologist
Phillip
Blanchette
MD
Medical
Oncologist
Geoffrey
Liu
MD, FRCPC, FISPE
Scott
North
MPHE, MD, FRCPC
Christine
Simmons
MD, MSc, FRCPC

Tallal Younis
NOYCIA Chair
MBBCh, FRCP (UK)

Dr. Younis is a professor of medicine at Dalhousie University, and a consultant medical oncologist at the Queen Elizabeth II Health Sciences Centre (QE II HSC) in Canada. He received his medical degree from Cairo University in 1992 and an MRCP degree from the United Kingdom in 1998. He completed an internal medicine residency in 2001 at the Columbia University and a medical oncology fellowship in 2003 at the Roswell Park Cancer Institute in the USA.

Dr. Younis clinical practice is devoted to breast cancer, and he is board certified (ABIM) in internal medicine and medical oncology. He is the research director for medical oncology at the QEII HSC, and an editor for “Current Oncology” journal. His research interests involve health services research and health technology assessments in breast cancer.

JAMIL ASSELAH
MD, Medical Oncologist

Trained in Algiers and Paris as a medical oncologist, Dr. Asselah completed a 2-year fellowship on phase 1 clinical trials at the Investigation Unit of the Curie Institute Cancer Centre in Paris, France.

In 2008, he joined the Université de Sherbrooke as an Assistant Professor, developing new research protocols in breast cancer and standardizing treatment practices at the Centre Hospitalier Universitaire de Sherbrooke, where he also launched the oncology residency program.
He joined McGill in 2011 as an Assistant Professor in the Department of Oncology and is now Associate Professor and director of Oncology Undergraduate Medical Education. He is on staff as a medical oncologist at the McGill University Health Centre, where he spearheaded a working group standardizing treatment guidelines for breast cancer. He was the first Site Lead for the Rossy Cancer Network.

Dr. Asselah has been the principal investigator in numerous clinical research protocols, and has been part of several research groups at the Provincial and National level. His research interests include Breast Cancers, Gastrointestinal Cancers, and Cancers of the Head and Neck.

Phillip Blanchette
MD, Medical Oncologist

Dr. Blanchette is a medical oncologist at the London Regional Cancer Program and an assistant professor of oncology at the University of Western. He received his MD from the University of Ottawa and postgraduate training in internal medicine and medical oncology at The University of Toronto. Dr. Blanchette completed a specialized breast cancer fellowship at the Sunnybrook Odette Cancer Centre under the supervision of Dr. Kathleen Pritchard. He also has completed a MSc in Clinical Epidemiology and Health Care Research at The Institute of Health Policy, Management and Evaluation at The University of Toronto. He is currently a member of the ICES Faculty Scholars Program.

Dr. Blanchette’s clinical expertise are in breast and lung cancers. His research interests include clinical trials and health services research evaluating population based cancer outcomes and late effects from cancer treatment.

Geoffrey Liu
MD, FRCPC, FISPE

Dr. Geoffrey Liu , MD FRCPC FISPE is the Alan B. Brown Chair in Molecular Genomics, a thoracic medical oncologist, and Professor of Medicine, Medical Biophysics, Epidemiology, and at the Institute of Medical Science at the University of Toronto and the Dalla Lana School of Public Health. He is Senior Scientist at the Ontario Cancer Institute, and runs the Applied Molecular Pharmacogenomic Profiling and Epidemiological Laboratory (AMPPEL). He is a Fellow of the International Society for Pharmacoepidemiology, where he is on the committee for developing real world evidence guidelines for the society. His research interests are in clinical, germline, and somatic pharmacogenomics, secondary resistance patterns in targeted agent therapy, utilizing primary derived xenograft and organdies to identify biomarkers of susceptibility and resistance to targeted agents, routine collection of patient-reported and health utility data, and regulatory grade real world evidence methodology.

Scott North
MHPE, MD, FRCPC

Scott North received his MD degree from the University of Ottawa and then completed Internal Medicine and Medical Oncology training at the University of Alberta. He has a keen interest in medical education, also obtaining a Masters in Health Professions Education from the University of Illinois at Chicago. He is a Professor in the Department of Oncology at the University of Alberta and currently the Section Chief of Medical Oncology at the Cross Cancer Institute in Edmonton and the Division Head of Medical Oncology within the Department of Oncology at the University of Alberta. His clinical interests are in the area of genitourinary oncology and he is an active clinical trialist. He is currently a member of the national executive of the Candadian Uro-Oncology Group (CUOG) and the GU site of the CCTG.

Christine Simmons
MD, MSc, FRCPC

Dr. Christine Simmons is a Medical Oncologist at the BCCA Vancouver and Clinical Associate Professor in the Department of Medicine at the University of British Columbia. She completed her residency training in Toronto, and completed a fellowship at Princess Margaret Hospital in Toronto. She also completed a Master’s in Clinical Epidemiology at University of Toronto. She is currently the Chair of Sarcoma Systemic Program for BCCA. She is the former chair of the Locally Advanced Breast Cancer National Consensus group and still plays a key role in that organisation. Her academic interests span both teaching and research, and she has held several leadership roles in the Undergraduate Medical Program at UBC in the areas of clinical skills and oncology education. Her research interests are in the areas of health services research in breast cancer and sarcoma. She recently founded the Sarcoma Outcomes Unit at the BC Cancer Agency, and is Founder and Chair of the not-for-profit organisation, Women in Cancer.